Merge upgrades Fysicons image portal

TriMed Staff | | Health Imaging | Practice Management
IT health company Merge Healthcare will be expanding its relationship with Dutch imaging distributor Fysicon by customizing the company’s Evocs image management portal.

Under the new agreement, Chicago-based Merge will upgrade Evocs with a new image viewer, make the product zero footprint and work at developing a vendor-neutral Evocs. Fysicon, which distributes imaging products for radiology and cardiology, says it has transported more than 60 million images through its Evocs portal.

Headquartered in Oss, the Netherlands, Fysicon said it will be showcasing the new product at Zorg & ICT Congress in Utrecht, the Netherlands.

TriMed Staff

Related Content

Imaging leaders share 7 key considerations for remote scanning programs
Policies and regulations shaping radiology in 2025
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
Bracco's latest move marks a step toward improving sustainability in radiology
New protocol addresses contrast allergies in patients with suspected stroke

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.